Risk of avascular necrosis following short term megadose methylprednisolone treatment
نویسندگان
چکیده
منابع مشابه
Megadose methylprednisolone for Evans syndrome.
I was pleased to read Berber et al’s 50 year-old patient with Evans syndrome which was published as a Letter to The Editor in the recent issue of the Journal of Turgut Ozal Medical Center (2013;20(3):289-290). But, it was surprised to me that mega dose methyl prednisolone (MDMP) treatment was not brought to attention which had been successfully used for these patients first time from our countr...
متن کاملMegadose methylprednisolone for granulocytic sarcoma.
Kaya et al.’s [1] case report entitled “Granulocytic sarcoma after stem-cell transplantation in a child with biphenotypic leukemia” gives me an opportunity to remind physicians that short-course megadose methylprednisolone (MDMP; daily, 30 mg/kg for 3 days then 20 mg/kg for 4 days) has been effectively used in the treatment of granulocytic sarcoma (GS) [2-4]. With this treatment, extramedullary...
متن کاملMegadose Methylprednisolone (MDMP) for Hemangiomatosis
Dr. Küpeli and his colleagues[1] should be congratulated for their success in treating hemangiomatosis, which could be life threatining depending on the localization of hemangiomas, with propranolol. I prefer the term infantile hemangiomatosis instead of segmental hemangiomatosis[ 2] for the authors’ patient. My primary reason in writing this letter is to clarify MDMP treatment, which caused se...
متن کاملMegadose Methylprednisolone (MDMP) for Hemangiomatosis
Reply In response to " Megadose Methylprednisolone (MDMP) for Hemangiomatosis " We are grateful to Dr. Özsoylu for his valuable comments on our case report concerning the treatment of hemangiomatosis with propranolol [1]. One of the issues raised by Dr. Özsoylu is regarding with the terminology used to describe hemangiomatous lesions. Although the term infantile hemangiomatosis could be used so...
متن کاملOral megadose methylprednisolone for Diamond-Blackfan anemia.
I have read the report of Olivieri et al’ in the May 1, 1994 issue of BLOOD. Although the investigators stated that “in standard practice, treatment options are limited to two: steroid therapy or RBC transfusions,” they ignore our very good results obtained with megadose methylprednisolone (MDMP; initial dose 30 to 100 mgkg/d for 3 days followed progressive halving of the dose every 4 to 7 days...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Spinal Cord
سال: 1998
ISSN: 1362-4393,1476-5624
DOI: 10.1038/sj.sc.3100647